The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  September 2018 Next

EFMC Sponsorship rules can be found in the by-laws, point E.

  • Macrocycles 2018 - 3rd RSC BMCS Medicinal Chemistry Symposium on Macrocycles

    October 8-9, 2018   Stevenage, United Kingdom

    The objective of this symposium is to promote scientific interaction between scientists with a shared interest in the field of Macrocycles. This area is responsible for a growing number of therapeutic approaches and development candidates, all of which go ‘beyond the rule-of–five’. As a researcher in this field, come along to hear about the latest advances and also to share in some of the secrets of discovering therapeutic agents which go beyond Lipinski’s rules.

    Confirmed Speakers

    • Frank Fang, Eisai, United States
    • William McCoull, AstraZeneca, United Kingdom
    • Daniel Obrecht, Polyphor, Switzerland
    • Vicky Steadman, Selcia, United Kingdom

    Contact person: Mrs Maggi Churchouse
    Email: maggi@maggichurchouseevents.co.uk
    Tel: +44 (0)1359 221004


  • 2nd SCI/RSC Symposium on Antimicrobial Drug Discovery

    November 12-13, 2018   London, United Kingdom

    Rising antimicrobial resistance is decreasing the efficacy of existing treatments for infection. With the alarming prospect of a post-antibiotic era, it is vital that we refresh the drug pipeline with new therapies and therapeutics that act through novel modes of action. With pressure from governments and increased public awareness of this growing problem, renewed interest from industry and academia has led to a resurgence in antimicrobial drug discovery, with the exciting prospect of new and innovative technologies and approaches for combating infection.

    Following the first successful event in 2016, this meeting will examine the current state of the art in antimicrobial drug discovery from a medicinal chemist’s perspective. Coinciding with World Antibiotics Awareness week, a two-day programme of speakers from industry and academia will highlight the challenges associated with discovering and developing new antimicrobials, whilst also showcasing emerging strategies that are being developed to tackle infection.

    Early-career researchers wishing to give a short talk are encouraged to submit a one-page abstract by Friday 15 June 2018.

    Deadline for early bird registration is 1st October 2018.

    Contact: Conference Team
    Email: conferences@soci.org
    Tel: +44 (0)207 598 1561

  • MedChem 2018: New Avenues in Kinase Drug Discovery: a Bright Future ?

    November 23, 2018   Namur, Belgium

    The Medicinal Chemistry Divisions of the two Belgian Chemical Societies, Société Royale de Chimie (SRC)  and Koninklijke Vlaamse Chemische Vereniging (KVCV), are organising every year an international one-day symposium with the aim to update participants on selected areas of pharmaceutical research by specialists in their respective field.

    In recent years, this symposium has been gathering around 150 participants at each edition, half from universities, half from industry, both from Belgium and surrounding countries. It has been focussing on topics such as:

    • The Many Pharmacotherapeutic Faces of Nucleosides and Oligonucleotides (2017)
    • PET & Imaging : From Chemistry Lab to Clinical Applications (2016)
    • New Vistas in GPCR Research: the Dawn of an Exciting Drug Discovery Era? (2014)
    • Constrained Peptides and Macrocycles – New Opportunities for Drug Discovery (2013)
    • From Rapid Dissociation to Irreversible Inhibition – Optimisation of Drug-Target Residence Time (2012)

    Confirmed Speakers

    • Dr Patrick ANGIBAUD, JANSSEN, Val de Reuil, France
    • Prof. Jürgen BAJORATH, UNIVERSITY OF BONN, Bonn, Germany
    • Dr Ulrich LUCKING, BAYER HEALTHCARE, Berlin, Germany
    • Dr James REUBERSON, UCB, Slough, United Kingdom

    Deadline for abstract submission and early bird fee is October 16, 2018!

M T W T F S S
27 28 29 30 31 01 02
03 04 05 06 07 08 09
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
01 02 03 04 05 06 07
All events   |  Future events

Job portal

27/04/2018
MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck